Jeffrey Baxter to Analgesics, Opioid
This is a "connection" page, showing publications Jeffrey Baxter has written about Analgesics, Opioid.
Connection Strength
0.325
-
Roy P, Jackson AH, Baxter J, Brett B, Winter M, Hardesty I, Alford DP. Utilizing a Faculty Development Program to Promote Safer Opioid Prescribing for Chronic Pain in Internal Medicine Resident Practices. Pain Med. 2019 04 01; 20(4):707-716.
Score: 0.106
-
Clark RE, Baxter JD, Aweh G, O'Connell E, Fisher WH, Barton BA. Risk Factors for Relapse and Higher Costs Among Medicaid Members with Opioid Dependence or Abuse: Opioid Agonists, Comorbidities, and Treatment History. J Subst Abuse Treat. 2015 Oct; 57:75-80.
Score: 0.081
-
Clark RE, Baxter JD, Barton BA, Aweh G, O'Connell E, Fisher WH. The impact of prior authorization on buprenorphine dose, relapse rates, and cost for Massachusetts Medicaid beneficiaries with opioid dependence. Health Serv Res. 2014 Dec; 49(6):1964-79.
Score: 0.076
-
Clark RE, Samnaliev M, Baxter JD, Leung GY. The evidence doesn't justify steps by state Medicaid programs to restrict opioid addiction treatment with buprenorphine. Health Aff (Millwood). 2011 Aug; 30(8):1425-33.
Score: 0.062